Gardner Lewis Asset Management’s Avidity Biosciences RNAM Stock Holding History

Gardner Lewis Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-158,959	Closed	-$11.5M	–	99
2025 Q4	$11.5M	Buy	+158,959	New	+$10.3M	2.91%	11

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Gardner Lewis Asset Management's RNAM Position: Q1 2026 in Review

Gardner Lewis Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 158,959 shares — an estimated $11.5M sold.

Gardner Lewis Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $11.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Gardner Lewis Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Gardner Lewis Asset Management sold 158,959 Avidity Biosciences shares in Q1 2026, an estimated $11.5M.
Gardner Lewis Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Gardner Lewis Asset Management's Avidity Biosciences position peaked at $11.5M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2026, filed 8 May 2026.